Site icon OncologyTube

Ovarian Cancer Treatment Trends for 2017 Includes Chemotherapy, PARP Inhibitors, and Bevacizumab

Don Dizon, MD of Massachusetts General Hospital gives an overview of the treatment trends for 2017 in ovarian cancer treatment, which were discussed at the 2017 Society of Gynecologic Oncology (SGO)s Annual Meeting on Womens CancerĀ® in National Harbor, MD.

Exit mobile version